Lanean...
Polaprezinc reduces the severity of radiation-induced mucositis in head and neck cancer patients
Polaprezinc (PZ), an antiulcer drug, has been reported to have antioxidant properties. The aim of the present study was to assess the feasibility and efficacy of administering PZ for radiation-induced mucositis in head and neck cancer patients. Patients with newly diagnosed head and neck cancer were...
Gorde:
| Argitaratua izan da: | Mol Clin Oncol |
|---|---|
| Egile Nagusiak: | , , , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
D.A. Spandidos
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4360858/ https://ncbi.nlm.nih.gov/pubmed/25798271 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2014.479 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|